JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
102 hedge funds and large institutions have $92.7M invested in Jounce Therapeutics, Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 29 increasing their positions, 35 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
17% less repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 35
23% less capital invested
Capital invested by funds: $120M → $92.7M (-$27.8M)
Holders
102
Holding in Top 10
2
Calls
$437K
Puts
$162K
Top Buyers
| 1 | +$3.28M | |
| 2 | +$1.88M | |
| 3 | +$1.75M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$986K |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
+$714K |
Top Sellers
| 1 | -$2.98M | |
| 2 | -$1.81M | |
| 3 | -$1.67M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.34M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$985K |